- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CDRH names permanent director
Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agency’s Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and
Food and Drug Administration Commissioner Dr. Jane Henney this month appointed Dr. David Feigal director of the agencys Center for Devices and Radiological Health. Feigal replaces former director Dr. Bruce Burlington, who left the FDA in March, and acting director Elizabeth Jacobson (SCAN 3/3/99). Feigals new position is effective immediately.
Feigal joined the FDA in 1992, and has served as head of the Center for Drug Evaluation and Researchs division of antiviral drug products and as medical deputy director of the FDAs Center for Biologics Evaluation and Research. He was a principal investigator in studies that led the FDA to approve a drug-device combination that was one of the earliest therapies for AIDS.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
